Patent office proceedings
Patent strategy & counseling
Bindu Donovan is a partner in Desmarais LLP’s Life Sciences Practice, focusing on pharmaceutical and medical device litigation. She has more than two decades of experience in life sciences patent litigation, and has significant experience handling cases filed under the Hatch-Waxman Act on behalf of innovator drug companies. She has represented some of the world’s leading life sciences companies in high stakes patent disputes, including cases involving cancer, influenza, diabetes, neurological and ophthalmic disorders, biotechnology, and drug-eluting stents.
Ms. Donovan has served as trial and litigation counsel for a variety of complex intellectual property and patent litigation matters. Most recently, Ms. Donovan served as trial and litigation counsel for Johnson & Johnson subsidiary, Janssen Pharmaceuticals, in patent infringement suits filed under the Hatch-Waxman Act and inter partes review proceedings involving blockbuster prostate cancer drug, Zytiga®. Ms. Donovan also served as litigation counsel for Gilead and Roche/Genentech in patent infringement litigation involving Tamiflu®. And Ms. Donovan served as litigation counsel for Johnson & Johnson subsidiary, Cordis Corporation, in patent infringement suits involving the Cypher stent.
Ms. Donovan was named as one of the Top 250 Women in Litigation (2013-2018) and as a Local Litigation Star (2017-2018) by Benchmark Litigation, a publication honoring the achievements of lawyers in litigation practices in the United States. In addition, Ms. Donovan was recognized for her life sciences-related patent work by LMG Life Sciences and as an “IP Star” by Managing Intellectual Property.
Ms. Donovan began her career as an associate at Fish & Neave in 1998. In 2005, Ms. Donovan moved to Sidley Austin LLP’s New York office, and in 2008 she was elevated to partner in the firm’s Intellectual Property Litigation Practice. She joined Desmarais LLP as a partner in 2018.
American Bar Association, New York Intellectual Property Law Association
Last updated 13th May 2019